How much loose skin after GLP-1 weight loss you develop depends on several factors: the total amount of weight lost, the pace of that loss, your age, skin elasticity, and which areas carried the most volume
5lbs down and minimal side effects besides surprised appetite Im into my first month
Additionally, per publicly available FDA and manufacturer announcements, orforglipron (Eli Lilly's Foundayo, a non-peptide oral GLP-1 receptor agonist) received FDA approval on April 1, 2026 for chronic weight management
In vitro research use only Not for human or animal use peptides PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist studied in MC3R/MC4R pharmacology and central nervous system signaling research
Weight regain is visible, the metabolic reversal is not. CNBC reported that GLP1s are practically everywhere roughly 1 in 8 US adults take one, and that discontinuation rates run as high as 36 percent to 81 percent in several studies, driven by access challenges and side effects such as nausea and vomiting
